Mark S. Levine - Jan 26, 2023 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Signature
/s/ Eva Renee Barnett, attorney-in-fact for Mark S. Levine
Stock symbol
IMVT
Transactions as of
Jan 26, 2023
Transactions value $
-$187,988
Form type
4
Date filed
1/27/2023, 06:20 AM
Previous filing
Aug 19, 2022
Next filing
Apr 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Sale -$188K -10.2K -3.97% $18.51 246K Jan 26, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 28, 2022, the holder was granted 143,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on January 31, 2022, of which 35,750 of these RSUs vested on January 19, 2023. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.